Question 1

Does Morgan Stanley own INKT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Morgan Stanley holds 113 shares of INKT (Mink Therapeutics), worth $1,321.

Question 2

How many shares of INKT does Morgan Stanley own?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley holds 113 shares of INKT (Mink Therapeutics).

Question 3

What is Morgan Stanley's INKT position worth?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley's INKT position is worth $1,321.

Question 4

Is Morgan Stanley buying or selling INKT?

Accepted Answer

In Q2 2026, Morgan Stanley increased its INKT position by 9 shares (+8.7%).

Question 5

When did Morgan Stanley first buy INKT?

Accepted Answer

Morgan Stanley first reported INKT in its Q1 2025 13F and has listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	113	+8.7%	$1,321	0.0%	$11.69	8
2026-Q1	Unchanged	104	0.0%	$1,095	0.0%	$10.53	0
2025-Q4	Decreased	104	-9.6%	$1,160	0.0%	$11.15	0
2025-Q3	Increased	115	+422.7%	$1,610	0.0%	$14.00	12
2025-Q2	Decreased	22	-8.3%	$163	0.0%	$7.39	0
2025-Q1	New	24	-	$208	0.0%	$8.64	17

INKT6 quarters

INKT
6 quarters